Wyeth R&D President Robert Ruffolo: An Interview With “The Pink Sheet” DAILY
This article was originally published in The Pink Sheet Daily
Executive Summary
With Wyeth’s NDA for Torisel pending at FDA April 5, exec outlines Wyeth’s early-stage oncology pipeline in an interview with “The Pink Sheet” DAILY.